Zai Lab Patents – Insights & Stats

Zai Lab has a total of 23 patents globally, out of which 13 have been granted. Of these 23 patents, more than 82% patents are active. China is where Zai Lab has filed the maximum number of patents, followed by Europe. Parallelly, China seems to be the main focused R&D centre.

Zai Lab was founded in the year 2014 by Samantha DU. The company is a biopharmaceutical company which is focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients. As of December 2022, Zai Lab has a market cap of $3.03 Billion.

Do read about some of the most popular patents of Zai Lab which have been covered by us in this article and also you can find Zai Lab patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Zai Lab patent portfolio.

How many patents does Zai Lab have?

Zai Lab has a total of 23 patents globally. These patents belong to 13 unique patent families. Out of 23 patents, 19 patents are active.

How Many Patents did Zai Lab File Every Year?

Zai Lab Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantZai Lab Applications FiledZai Lab Patents Granted
2022 –4
2021 –2
202076
20194
201811
2012 –1

How many Zai Lab patents are Alive/Dead?

Zai Lab Patent Portfolio

How Many Patents did Zai Lab File in Different Countries?

Zai Lab Worldwide Patent Filing

Where are Research Centres of Zai Lab Patents Located?

Research Centres of Zai Lab Patents

List of Zai Lab Patents

Zai Lab PatentsTitle
ES2923138T3procedure to prepare an intermediate of the Niraparib antitumor and intermediate
EP3694836B1Process for preparing intermediate of Anti-tumor drug niraparib and intermediate thereof
DE602018036876T2METHOD OF MANUFACTURE OF AN INTERMEDIATE OF ANTI-TUMORS DRUG NIRAPARIB AND INTERMEDIATE THEREOF
IT202200044635T2process FOR THE PREPARATION OF AN INTERMEDIATE OF THE ANTI-CANCER DRUG NIRAPARIB AND ITS INTERMEDIATE.
CN113423735AAnti-claudin antibodies and uses thereof
KR102221087B1Intermediate manufacturing method and intermediate for synthesizing anti-tumor drug niraparib
US10927077B2Process for preparing intermediate of anti-tumor drug niraparib and intermediate thereof
IL273890AProcess for preparing intermediate of Anti-tumor drug niraparib and intermediate thereof
CN306031911SMedicine Packaging Box (2)
CN306031912SMedicine Box(3)
CN306031910SMedicine Box (1)
HK40015810ACd47 antigen binding unit and uses thereof
CN305841944SMedicine Box (2)
CN305841945SMedicine Box (1)
IN202047018936AProcess for preparing intermediate of Anti-tumor drug niraparib and intermediate thereof
WO2020114480A1Anti-claudin antibodies and uses thereof
CN111253486AAnti-PD-1 antibody and application thereof
WO2020063823A1Anti-pd-1 antibodies and uses thereof
CN109265390BA kind of preparation method and intermediate for the intermediate of synthetic antineoplastic drug niraparib
CN110461872ACD47 antigen binding unit and uses thereof
WO2019072237A1Process for preparing intermediate of Anti-tumor drug niraparib and intermediate thereof
WO2018137705A1Cd47 antigen binding unit and uses thereof
CN101564420BChinese medicinal herb composition for treating skin disease

What are Zai Lab key innovation segments?

What Technologies are Covered by Zai Lab?

The chart below distributes patents filed by Zai Lab in different countries on the basis of the technology protected in patents. It also represents the markets where Zai Lab thinks it’s important to protect particular technology inventions.

R&D Focus: How has Zai Lab search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Zai Lab?

Related Articles

Svitzer Patents – Insights & Stats (Updated 2024)

Svitzer has a total of 179 patents globally, out of which 96 have been granted. Of these 179 patents, more than 73% patents are active. Europe (EPO) is where Svitzer has filed the maximum number of patents, followed by Australia and China. Parallelly, Europe (EPO) seems to be the main

Read More »

Qufora Patents – Insights & Stats (Updated 2024)

Qufora has a total of 49 patents globally, out of which 29 have been granted. Of these 49 patents, more than 95% patents are active. Europe (EPO) is where Qufora has filed the maximum number of patents, followed by United States of America and Denmark. Parallelly, Denmark seems to be

Read More »

Fidlock Patents – Insights & Stats (Updated 2024)

Fidlock has a total of 1273 patents globally, out of which 1063 have been granted. Of these 1273 patents, more than 88% patents are active. Germany is where Fidlock has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Germany seems to be the main focused

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.